Verastem, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Verastem, Inc. (VSTM) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $46.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-04
- Verastem, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $46.00M, a 142.11% increase from fiscal 2024.
- Verastem, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $19.00M, a 2.70% increase from fiscal 2023.
- Verastem, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $18.50M, a 17.09% increase from fiscal 2022.
- Verastem, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $15.80M, a 4.64% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 5 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 41 month |
|---|---|---|---|---|
| 2025-12-31 | $46.00M 10-K · filed 2026-03-04 | |||
| 2024-12-31 | $19.00M 10-K · filed 2025-03-20 | |||
| 2023-12-31 | $18.50M 10-K · filed 2024-03-14 | |||
| 2022-12-31 | $15.80M 10-K · filed 2023-03-14 | |||
| 2021-12-31 | $15.10M 10-K · filed 2022-03-28 | |||
| 2020-12-31 | -$25.50M 10-K · filed 2021-03-18 | |||
| 2019-12-31 | $26.60M 10-K · filed 2020-03-11 | |||
| 2018-12-31 | $16.00M 10-K · filed 2019-03-12 | |||
| 2017-12-31 | -$129.00K 10-K · filed 2018-03-13 | |||
| 2016-12-31 | $13.40M 10-K · filed 2017-03-23 | |||
| 2015-12-31 | $24.20M 10-K · filed 2017-03-23 | |||
| 2014-12-31 | $18.30M 10-K · filed 2016-03-03 | |||
| 2013-12-31 | $14.50M 10-K · filed 2016-03-03 | $29.70M 10-K · filed 2014-03-06 | ||
| 2012-12-31 | $10.30M 10-K · filed 2015-03-10 | $320.00K 10-K · filed 2013-03-26 | ||
| 2011-12-31 | $4.90M 10-K · filed 2014-03-06 | |||
| 2010-12-31 | $10.30M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |